From the Journals
The highest-risk AEDs were zonisamide, rufinamide, clorazepate, lamotrigine, carbamazepine, and phenytoin.
PARIS – Multiple phase 3 trials are underway for this promising agent.
Daily News Podcast
And beware a nasty skin souvenir from travel abroad.
LAKE TAHOE, CALIF. – Mosaicism “can affect any tissue, anywhere, in any pattern,” expert says.
A pivotal phase 2/3 trial of bertilimumab will begin next year, according to the company.
Make the Diagnosis
A 75-year-old man presented with asymptomatic annular plaques on both arms, thighs, abdomen, and buttocks, present for several months.